SCHEMBL3467170

SCHEMBL3467170

OCC(Cc1ccccc1)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.47
SLC6A2 P23975 5/20 0.44
SLC6A4 P31645 4/20 0.44
SLC6A3 Q01959 3/20 0.44
TRPA1 O75762 1/20 0.43
KDM4E B2RXH2 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTPRA P18433 1/20 0.41
CYP1A2 P05177 2/20 0.41
ALDH1A1 P00352 1/20 0.41
KCNA5 P22460 4/20 0.40
CYP19A1 P11511 1/20 0.40
KCNE1 P15382 1/20 0.40
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1858714 0.85 TSHR (0.57) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL29520732 0.85 TSHR (0.57) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL27813115 0.79 SLC6A2 (0.48) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL27946805 0.79 SLC6A2 (0.48) TSHRSLC6A2SLC6A4SLC6A3KDM4E
Carbamic Acid SCHEMBL8397235 0.79 CYP1A2 (0.47) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL24126990 0.78 TSHR (0.55) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL27833164 0.78 SLC6A2 (0.47) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL11029621 0.76 CYP1A2 (0.46) TSHRKDM4EPTPRACYP1A2ALDH1A1
SCHEMBL7035596 0.74 SLC6A2 (0.47) TSHRSLC6A2SLC6A4SLC6A3KDM4E
SCHEMBL30321061 0.74 SLC6A2 (0.50) TSHRSLC6A2SLC6A4SLC6A3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391606-A1 ETHANAMINE COMPOUNDS AND THEIR USE FOR TREATING DEPRESSION AstraZeneca AB (SE) 2011-12-07 EP disclosed
WO-2010074647-A1 ETHANAMINE COMPOUNDS AND THEIR USE FOR TREATING DEPRESSION ASTRAZENECA AB (SE) 2010-07-01 WO disclosed